Department of Anaesthesia and Critical Care
Edinburgh, United Kingdom
NCT Number: NCT02471001
In the last few years, anaesthetic agents, Isoflurane used in heart surgery have shown some benefits to reduce the risk of heart muscle damage. Many research studies have been conducted to reveal the benefit relationship between Isoflurane and the risk of heart muscle injury during heart surgery. However, there is a knowledge gap regarding the optimal level of Isoflurane concentration to confer the benefit of heart muscle-protective properties. Therefore, this study is conducted to answer that question by measuring the Isoflurane concentration in the blood vessels. It also assesses whether Isoflurane concentration in the blood is correlated to the oxygenator exhaust level of Isoflurane in the heart-lung machine.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Edinburgh, United Kingdom
All patients who scheduled for an elective heart surgery in Royal Infirmary of Edinburgh using a heart-lung machine and the administration of ether-like anaesthetic, isoflurane will be recruited in this study. This is a pilot study to determine the concentration of isoflurane in heart muscle. Isaac and Michael (2005), Hill (1998), Julious (2005) have conducted survey/research to conclude that 30 sample sizes are adequate for a pilot study. Thus, investigators aim to recruit at least 30 sample sizes to allow data (standard deviation, mean etc.) used in sample size estimation for future studies.
The medical and surgical care plans for participants remain as usual in this study. In a normal practise, surgeons will insert a catheter into the blood vessels coming from the heart to deliver solution to stop the contraction of heart for heart procedure. At this moment, two blood samples of about two-teaspoonful in volume will be collected from the in-placed catheters in vein and aorta. Then, the blood samples will be sent to lab to measure the concentration of isoflurane in vein and aorta. Also, the reading of exhausted isoflurane gas on heart-lung machine are routinely monitored and recorded.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two additional blood samples will be taken from in-situ catheters during heart surgery.
Time frame: 1 week after blood samples taken
Time frame: Immediately after the heart surgery is over
University of Edinburgh
Other
Coronary Sinus Blood Isoflurane Concentration in Patients Undergoing Heart Surgery
Acronym: TLAHMHS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04754022
Cardiac Surgery, Disease
Portland, Maine, United States
View Trial DetailsNCT03772990
Cardiac Surgery, Cardiopulmonary Bypass
Manama, Bahrain
View Trial DetailsNCT07725445
Arrhythmias, Cardiac, Cardiac Arrhythmias
Seoul, South Korea
View Trial DetailsNCT07736066
Cardiac Rehabilitation, Cardiac Surgery
Seoul, South Korea
View Trial Details